• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of industry meetings attended within the month

Dictionary: Number of industry meetings held, including face-to-face meetings and meetings held over the telephone, within the month that OBP participated in. These meeting facilitate communication with industry to help ensure appropriate product development.


These measures have been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/A30
Nov 2011N/A30
Dec 2011N/A26
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

FY 2012 YTD: 86

Number of OBP-managed product quality meetings, held with industry within the month

Dictionary: Number of OBP-managed product quality meetings, including teleconferences and in-person meetings, held with industry within the month. These meeting facilitate communication with industry to help ensure appropriate product development. However they are focused on product quality, manufacturing and related safety issues.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/A7
Nov 2011N/A4
Dec 2011N/A4
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

FY 2012 YTD: 15

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.